500 Boylston Street, Boston, MA 02116 617-419-4700
Return to Results
The purpose of this study is to compare the effects (good and bad) of the combination of docetaxel and prednisone plus atrasentan against the combination of docetaxel and prednisone plus placebo in patients with prostate cancer to see which is better.
Sponsor: National Cancer Institute, SWOG
Phase: Phase 2
Trial ID: CGS026
Not Accepting Healthy Volunteers